Measuring brain cell atrophy is expensive. That may be changing.

In Brain Disorders, Brain Science, Brain Technology by Brainy Days Ahead

Starting in August, 2016, University at Buffalo researchers will be testing in the U.S., Europe, Australia and Latin America a new software tool they developed that could make assessing brain atrophy part of the clinical routine for MS patients.  Brain atrophy is a normal part of aging, but multiple sclerosis (MS) accelerates the process. The cost of measuring it on a regular basis for MS patients has previously be cost prohibitive. Faster, please.